Tony Caldwell helps clients navigate complex issues related to law and technology. His day-to-day practice focuses on corporate, technology and life sciences transactions and contracting matters, with an emphasis on licensing, manufacturing and supply chain, clinical trials, data use, cybersecurity, and mergers and acquisitions.
Tony assists clients from early- and mid-stage startups to public companies with developing, acquiring, monetizing, and protecting rights in their intellectual property and data across a diverse range of highly regulated industries, including apparel, home builders, SaaS, software, mobile apps, pharmaceuticals, diagnostic tests, medical devices, defense, and consulting services. He has significant experience with commercial contracting and supply chain management issues for clients involved in semiconductor management equipment (SME), electric vehicles, fiber optics, diagnostic instrumentation, batteries, and irrigation systems.
Life Sciences/Medical Devices
Tony advises biotechnology, pharmaceutical, medical device and diagnostics companies with commercial contracting and clinical matters, and he is a member of the firm’s Life Science and Medical Technology Industry Group. He has a comprehensive understanding of the legal needs of the life sciences industry, including its regulatory framework, risks and opportunities, rapidly changing technologies, and competitive landscape. He has extensive experience negotiating pre-clinical and clinical trial agreements, material transfer agreements, and domestic and international supply chain agreements. He has also represented several life sciences companies in connection with M&A transactions and IPOs.
From business associate agreements to electronic medical records compliance, Tony has extensive experience counseling healthcare providers on business and legal issues. He regularly represents various healthcare organizations, including hospitals, physician groups, pharmacists, chiropractors, surgery centers, assisted living facilities, home health agencies, clinical laboratories, and commercial insurers, as well as digital health and telehealth companies looking to innovate the healthcare industry. Prior to joining Snell & Wilmer, Tony represented one of the nation's largest nonprofit healthcare systems as deputized in-house technology counsel.
Tony advises international and U.S. companies with data privacy and healthcare regulatory matters and is a member of the firm’s Cybersecurity, Data Protection and Privacy Practice Group. He has particular experience assisting clients in cybersecurity preparedness, advising clients on potential risks and creating strategies before a cyberattack occurs, including cyber risk management programs, vendor assessment and management, privacy and information security policies, workforce training on privacy laws and best practices, and information governance. He has also represented many multinational companies in responding to cyber incidents involving ransomware and cyber extortion attacks resulting in exposure of sensitive information. He routinely assists companies with issues and drafting policies related to the EU GDPR, California Consumer Privacy Act, Privacy Shield, TCPA, COPPA, CAN-SPAM, PIPEDA, HIPAA, and HITECH.
Life Science and Medical Device
Represented publicly traded diagnostic testing company in negotiation of numerous development, manufacturing and supply chain agreements with international partners to scale COVID-19 testing capacity
Represented multiple lab testing companies in connection with COVID-19 testing arrangements with public, private and tribal entities
Represented publicly traded pharmaceutical company with establishing Phase II clinical trial program in India
Represented publicly traded pharmaceutical company with long-term leasing of research equipment
Represented international medical technology company with software licensing and SaaS agreements
Represented multiple medical diagnostics and pharmaceutical companies with joint development, manufacturing, supply, clinical trial and distribution arrangements in the U.S. and abroad
Mergers and Acquisitions
Represented privately held technology company specializing in enterprise software for the alcoholic beverage industry in its sale to a private equity fund
Represented privately held employee benefits company in buyout of co-founder
Represented gene-editing life sciences company with data and privacy due diligence in connection with IPO
Represented international consumer products company in connection with digital advertising complaint from U.S. regulatory authorities
Represented privately held technology company with development of data license agreements
Represented multiple national nonprofit healthcare systems as lead outside counsel for technology transactions
Represented venture-backed healthcare system in connection with physician group acquisitions
Advised multiple healthcare clients on regulatory compliance issues involving Medicare, Medicaid, Stark, Anti-Kickback, EKRA, Sunshine Act, FD&C Act, and the Affordable Care Act
University of Arizona, Rogers College of Law (J.D., cum laude, 2015)
Transactional Business and Health Law certificates
Wabash College (B.A., Biology, 2007)
NCAA All-American (Honorable Mention) and 2x Academic All-American, Swimming and Diving